I have been working at the Netherlands Cancer Institute since 2012 and am involved in oncological treatments in a study context. This means that the research focuses on safety and finding the right dosage of new drugs for the treatment of cancer. These new drugs specifically target certain proteins in a tumor. This brings individual pharmacotherapy one step closer
This translation was generated automatically based on information in Dutch. It has not been reviewed by a medical specialist. The purpose of this translation is to make our information accessible to non-Dutch speakers. However, this information should not be considered a substitute for medical advice from your treating physician. The Netherlands Cancer Institute cannot guarantee the accuracy of this translation. For medical questions or advice, please consult your physician.
We place cookies on our website to improve the user experience of our website. These cookies are essential for the proper functioning of our website.
Adjust preferences
Accept cookies!
nl